Skip to main content

Peer Review reports

From: The prognostic significance of histologic variant on survival outcomes in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitor therapy

Original Submission
10 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
18 Aug 2023 Reviewed Reviewer Report
24 Aug 2023 Reviewed Reviewer Report - Akihiko Matsumoto
8 Sep 2023 Author responded Author comments - Yu-Li Su
Resubmission - Version 4
8 Sep 2023 Submitted Manuscript version 4
Publishing
12 Sep 2023 Editorially accepted
15 Sep 2023 Article published 10.1186/s12885-023-11398-w

You can find further information about peer review here.

Back to article page